Enhanced agrobacterium tumefaciens vird2 protein for improved plant transformation
Leveraging high-throughput mutagenesis to enhance VirD2 protein variants, this solution aims to significantly increase the efficiency of Agrobacterium-mediated plant transformation, offering potential advancements in genetically modified crop production.
Overview
The essential protein VirD2 from Agrobacterium tumefaciens plays a crucial role in the genetic transformation of plants. This research focuses on enhancing the efficacy of VirD2 through high-throughput mutagenesis, aiming to significantly improve transformation rates. By identifying virulence variants that increase transformation efficiency, this methodology promises faster production of genetically modified plants, benefiting both agricultural industry applications and basic scientific research.
Technical specifications
The approach utilizes massively parallel mutagenesis methods, including deep mutational scans, to create a comprehensive library of VirD2 variants. Each variant undergoes a high-throughput transient assay using Nicotiana benthamiana, assessing the efficiency of DNA delivery. This method allows for the mapping of effective mutations to key functional domains of VirD2, such as ATP-binding, helicase, and type IV secretion signal. The scalable technique can handle up to 10^5 variants in a single experiment, ensuring thorough exploration of VirD2's potential enhancements.
Technology readiness level
Currently at TRL 4, this technology has been validated in controlled laboratory settings with a focus on identifying efficient VirD2 mutants. Future plans include testing these variants on various crop species to confirm their efficacy and potential for increasing the rate of single integration events in agricultural applications.
About University of Washington
The University of Washington is a large public research university with campuses in Seattle, Bothell, and Tacoma, known for a broad portfolio from fundamental discovery to applied innovation. Industry partners engage through a South Lake Union research campus adjacent to a major life sciences district and through collaboration programs that place faculty and students alongside corporate R&D. The university’s integration with a major academic health system enables clinical translation and large-scale trials. Research is supported by competitive federal funding from NIH, NSF, DOE, and DoD. A dedicated technology transfer office manages IP, licensing, and startup incubation with prototyping resources.
Inquire about this partnering listing
Industry applications
delivered to your inbox.